Lincoln Pharmaceuticals Limited

NSE:LINCOLN.NS

659.3 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32008 Q42007 Q4
Revenue 1,472.8181,424.931,464.4931,559.8781,356.1951,124.5961,337.6621,406.121,234.71986.6091,198.8031,274.6751,221.887701.4291,147.4711,260.6431,037.936688.169985.2391,126.872968.126700.594844.3491,026.036998.216673.355801.841896.541,348.6121,190.201735.487776.615891.6271,199.8621,045.179911.596732.341786.983645.158759.109469.495669.696519.94543.495379.538567.949510.995554.394295.449360.708545.29217.472260.444
Cost of Revenue 1,024.8281,013.156963.406738.274638.441484.997639.194675.911613.867466.458558.158599.748573.508261.786615.536601.534509.966359.469489.182555.423433.397422.381366.598528.899446.914250.214358.808455.6291,015.436932.117375.674355.29507.958936.36756.036621.755460.362676.988446.496508.57277.762535.349350.972355.856221.11458.438341.827366.26157.089300.186358.763207.741259.781
Gross Profit 447.99411.774501.087821.604717.754639.599698.468730.209620.843520.151640.645674.927648.379439.643531.935659.109527.97328.7496.057571.449534.729278.213477.751497.137551.302423.141443.033440.911333.176258.084359.813421.325383.669263.502289.143289.841271.979109.994198.662250.539191.733134.348168.968187.639158.428109.512169.168188.134138.3660.521186.5279.7310.663
Gross Profit Ratio 0.3040.2890.3420.5270.5290.5690.5220.5190.5030.5270.5340.5290.5310.6270.4640.5230.5090.4780.5030.5070.5520.3970.5660.4850.5520.6280.5530.4920.2470.2170.4890.5430.430.220.2770.3180.3710.140.3080.330.4080.2010.3250.3450.4170.1930.3310.3390.4680.1680.3420.0450.003
Reseach & Development Expenses 0000000000000000082.99600089.38300068.48100062.24600064.48500045.99500030.96400030.0180000000
General & Administrative Expenses 00000194.582000314.85100066.414000159.375000118.663000126.99500028.904000107.25400046.81900039.94100035.5370000000
Selling & Marketing Expenses 0000048.08500038.504000122.671000147.289000138.643000138.475000120.30600057.63600053.756000175.16000200.4260000000
SG&A 252.912254.802232.615260.726264.702242.667196.552210.931206.131353.355170.699158.274225.467189.085138.014136.221129.206306.664142.496154.123152.447257.306146.99127.307135.203265.471151.332133.778111.737149.209108.072123.342125.853164.8975.91473.356.694100.57447.2243.94443.246285.8648.54444.94548.806309.85852.0738.94700000
Other Expenses 104.09270.191110.17986.94776.90838.99263.57657.21564.94618.90926.35434.60620.10825.3497.2926.01817.979-68.51630.34725.23612.944-65.0713.79744.31822.9658.567267.142274.751248.402222.355256.483288.722216.955161.128170.506183.617168.939104.107146.434143.912131.14100.841108.69143.386116.6166.314143.8131.832115.89253.656161.7235.802-4.366
Operating Expenses 252.912254.802232.615535.924536.028497.335453.577465.417472.42355.665427.954402.134414.413305.591350.876380.411325.068235.081382.976342.351362.718173.492361.046321.353334.169341.952267.142274.751248.402222.355256.483288.722216.955161.128170.506183.617168.939104.107146.434143.912131.14100.841108.69143.386116.6166.314143.8131.832115.89253.656161.7235.802-4.366
Operating Income 195.078156.972268.472372.627181.726181.255308.468322.007148.422157.529212.691272.793233.966134.052181.059278.698202.90293.619113.081229.098172.011104.721116.705175.784217.13381.189175.891166.1684.77435.729103.33132.603166.714102.374118.637106.224103.045.88752.228106.62760.59333.50660.27844.25341.81843.19725.36856.30222.4686.86524.8043.9295.029
Operating Income Ratio 0.1320.110.1830.2390.1340.1610.2310.2290.120.160.1770.2140.1910.1910.1580.2210.1950.1360.1150.2030.1780.1490.1380.1710.2180.1210.2190.1850.0630.030.140.1710.1870.0850.1140.1170.1410.0070.0810.140.1290.050.1160.0810.110.0760.050.1020.0760.0190.0450.0180.019
Total Other Income Expenses Net 99.70165.199108.632-3.94272.74-11.482-3.319-1.460.83610.19323.30232.56616.35219.0733.3766.80411.24121.72616.87319.4326.484-25.521-3.2926.7759.639-0.828-13.678-14.958-16.079-17.677-13.484-17.681-21.104-40.839-20.164-18.726-19.8927.963-17.078-19.293-18.47-19.913-19.882-4.824-14.5232.014-13.598-11.506-10.4062.636-18.155-7.781-4.153
Income Before Tax 294.779222.171377.104368.685254.466169.773305.149320.607209.258167.723235.994305.359250.318153.125184.435285.502214.143115.345129.954248.53178.49579.199113.415202.559226.77280.361162.213151.20268.69518.05289.846114.922145.6161.53598.47387.49883.1533.8535.1587.33442.12313.59340.39639.42927.29545.21211.7744.79612.0629.5016.649-3.8520.876
Income Before Tax Ratio 0.20.1560.2570.2360.1880.1510.2280.2280.1690.170.1970.240.2050.2180.1610.2260.2060.1680.1320.2210.1840.1130.1340.1970.2270.1190.2020.1690.0510.0150.1220.1480.1630.0510.0940.0960.1140.0430.0540.1150.090.020.0780.0730.0720.080.0230.0810.0410.0260.012-0.0180.003
Income Tax Expense 58.06236.20196.70192.14364.33244.15789.02783.47859.14357.48559.97575.09273.29127.29549.60276.27961.53225.9420.7459.25151.729-5.93521.98852.47566.02912.09946.37637.97619.5268.2724.91328.17336.18420.61933.85120.49217.69611.5449.96414.79111.7445.85810.635.888-3.509-1.036-0.35815.9033.9881.7581.45500
Net Income 236.717185.97280.403276.542190.134125.617216.121237.129150.115110.238176.085230.245176.982125.725134.818209.119152.57489.444109.109189.145126.69484.95591.468149.999160.67968.316115.773113.03649.10410.00164.71286.62109.31540.17764.43266.82765.38822.01225.89769.92832.2846.96933.00934.15532.4140.89114.94632.7128.0747.6515.194-3.8520.876
Net Income Ratio 0.1610.1310.1910.1770.140.1120.1620.1690.1220.1120.1470.1810.1450.1790.1170.1660.1470.130.1110.1680.1310.1210.1080.1460.1610.1010.1440.1260.0360.0080.0880.1120.1230.0330.0620.0730.0890.0280.040.0920.0690.010.0630.0630.0850.0720.0290.0590.0270.0210.01-0.0180.003
EPS 11.829.281413.819.496.2710.7911.847.515.518.7911.58.846.296.7310.467.634.475.469.466.334.254.577.58.033.415.795.652.460.663.275.426.992.463.884.14.011.11.594.291.980.352.022.091.992.050.9220.50.380.32-0.50.11
EPS Diluted 11.829.281413.819.496.2710.7911.847.495.518.7911.58.846.296.7310.467.634.475.469.466.334.254.577.58.033.415.795.652.460.663.275.426.992.43.884.14.011.11.594.291.980.352.022.091.992.050.9220.50.380.32-0.50.11
EBITDA 227.321183.83296.61398.425284.087205.386331.088346.224234.061188.055260.856327.318273.24174.193207.31297.643239.664122.835162.255272.047203.42294.76139.894235.185255.9105.062189.834184.22998.57449.861117.93145.427180.525115.252131.687117.289114.44462.69863.459119.83171.72142.29569.42553.00750.39433.31631.55363.50527.622-3.80429.2876.7296.529
EBITDA Ratio 0.1540.1290.2030.2550.2090.1830.2480.2460.190.1910.2180.2570.2240.2480.1810.2360.2310.1780.1650.2410.210.1350.1660.2290.2560.1560.2370.2050.0730.0420.160.1870.2020.0960.1260.1290.1560.080.0980.1580.1530.0630.1340.0980.1330.0590.0620.1150.093-0.0110.0540.0310.025